HA14-1

  • CAT Number: I004476
  • CAS Number: 65673-63-4
  • Molecular Formula: C₁₇H₁₇BrN₂O₅
  • Molecular Weight: 409.23
  • Purity: ≥95%
Inquiry Now

HA14-1 (CAT: I004476) is a small molecule compound that has been studied for its potential as a Bcl-2 inhibitor. It was originally developed as a tool compound to investigate the role of Bcl-2 in apoptosis and has shown activity in preclinical studies. HA14-1 has been reported to disrupt the interaction between Bcl-2 and the pro-apoptotic protein Bax, leading to the activation of apoptosis in cancer cells. However, it is important to note that HA14-1 may have limitations and challenges in terms of its specificity, potency, and pharmacokinetic properties, which need to be considered in further development and application.

Catalog Number I004476
CAS Number 65673-63-4
Molecular Formula

C₁₇H₁₇BrN₂O₅

Purity 95%
Target Bcl-2 Family
Solubility 10 mM in DMSO
Storage 3 years -20C powder
IC50 9 μM
InChI InChI=1S/C17H17BrN2O5/c1-3-23-16(21)11(8-19)13-10-7-9(18)5-6-12(10)25-15(20)14(13)17(22)24-4-2/h5-7,11,13H,3-4,20H2,1-2H3
InChIKey SXJDCULZDFWMJC-UHFFFAOYSA-N
SMILES CCOC(=O)C1=C(OC2=C(C1C(C#N)C(=O)OCC)C=C(C=C2)Br)N
Reference

</br>1:HA14-1 potentiates apoptosis in B-cell cancer cells sensitive to a peptide disrupting IP 3 receptor / Bcl-2 complexes. Akl H, La Rovere RM, Janssens A, Vandenberghe P, Parys JB, Bultynck G.Int J Dev Biol. 2015;59(7-9):391-8. doi: 10.1387/ijdb.150213gb. PMID: 26260683 Free Article</br>2:Effect of HA14-1 on apoptosis-regulating proteins in HeLa cells. Rehman K, Tariq M, Akash MS, Gillani Z, Qazi MH.Chem Biol Drug Des. 2014 Mar;83(3):317-23. doi: 10.1111/cbdd.12245. Epub 2013 Dec 26. PMID: 24118733 </br>3:Regulation of HA14-1 mediated oxidative stress, toxic response, and autophagy by curcumin to enhance apoptotic activity in human embryonic kidney cells. Ranjan K, Sharma A, Surolia A, Pathak C.Biofactors. 2014 Jan-Feb;40(1):157-69. doi: 10.1002/biof.1098. Epub 2013 Apr 5. PMID: 23559532 </br>4:A small molecule inhibitor of Bcl-2, HA14-1, also inhibits ceramide glucosyltransferase. Niino S, Nakamura Y, Hirabayashi Y, Nagano-Ito M, Ichikawa S.Biochem Biophys Res Commun. 2013 Apr 5;433(2):170-4. doi: 10.1016/j.bbrc.2013.02.052. Epub 2013 Feb 26. PMID: 23485465 </br>5:HA14-1, but not the BH3 mimetic ABT-737, causes Ca2+ dysregulation in platelets and human cell lines. Akl H, Vandecaetsbeek I, Monaco G, Kauskot A, Luyten T, Welkenhuyzen K, Hoylaerts M, De Smedt H, Parys JB, Bultynck G.Haematologica. 2013 Apr;98(4):e49-51. doi: 10.3324/haematol.2012.080598. Epub 2013 Feb 12. No abstract available. PMID: 23403318 Free PMC Article</br>6:The BH3 mimetic HA14-1 enhances 5-fluorouracil-induced autophagy and type II cell death in oesophageal cancer cells. Nyhan MJ, O/’Donovan TR, Elzinga B, Crowley LC, O/’Sullivan GC, McKenna SL.Br J Cancer. 2012 Feb 14;106(4):711-8. doi: 10.1038/bjc.2011.604. Epub 2012 Jan 12. PMID: 22240779 Free PMC Article</br>7:Mitochondrial targeting by use of lipid nanocapsules loaded with SV30, an analogue of the small-molecule Bcl-2 inhibitor HA14-1. Weyland M, Manero F, Paillard A, Grée D, Viault G, Jarnet D, Menei P, Juin P, Chourpa I, Benoit JP, Grée R, Garcion E.J Control Release. 2011 Apr 10;151(1):74-82. doi: 10.1016/j.jconrel.2010.11.032. Epub 2010 Dec 5. PMID: 21138749 </br>8:HA14-1 sensitizes TNF-alpha-induced apoptosis via inhibition of the NF-kappaB signaling pathway: involvement of reactive oxygen species and JNK. Moon DO, Kim MO, Kang SH, Choi YH, Park SY, Kim GY.Cancer Lett. 2010 Jun 1;292(1):111-8. doi: 10.1016/j.canlet.2009.11.014. Epub 2009 Dec 22. PMID: 20022690 </br>9:Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells. Simonin K, Brotin E, Dufort S, Dutoit S, Goux D, N/’diaye M, Denoyelle C, Gauduchon P, Poulain L.Mol Cancer Ther. 2009 Nov;8(11):3162-70. doi: 10.1158/1535-7163.MCT-09-0493. Epub 2009 Nov 3. PMID: 19887550 Free Article</br>10:Bcl-2 inhibitor HA14-1 and genistein together adeptly down regulated survival factors and activated cysteine proteases for apoptosis in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells. Mohan N, Karmakar S, Choudhury SR, Banik NL, Ray SK.Brain Res. 2009 Aug 4;1283:155-66. doi: 10.1016/j.brainres.2009.05.097. Epub 2009 Jun 6. PMID: 19505441 Free PMC Article

Request a Quote

Contact Us at MuseChem

We are committed to providing you with reliable, cost-effective solutions for your chemical needs, while ensuring your safety and comfort. Our team of experts is always available to answer your questions and help you navigate the complexities of the chemical industry.

Whether you're looking for a specific product or need help with a custom synthesis project, we're here to help you discover a new world of chemical possibilities. Contact us today to learn more about how we can assist you with all of your chemical needs.

Our goal is to make the process of ordering chemicals as seamless and hassle-free as possible. Let us know how we can assist you, and we'll get back to you as soon as possible. We look forward to hearing from you!